Identifying diabetic ketoacidosis encounters at diagnosis among children with type 1 diabetes in claims data

R Brett McQueen1, Nai-Chia Chen1, Eric J Gutierrez1

  • 1University of Colorado Anschutz Medical Campus, Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO 80045, USA.

Insights

Claims data identify many, but not all, diabetic ketoacidosis (DKA) cases in new type 1 diabetes patients. DKA significantly increases inpatient encounters but reduces emergency room visits.

Area of Science:

  • Pediatric Endocrinology
  • Health Informatics
  • Diabetes Research

Background:

  • Diabetic ketoacidosis (DKA) is a serious complication of type 1 diabetes.
  • Accurate identification of DKA cases is crucial for understanding disease burden and resource utilization.
  • Claims data are increasingly used for health research but their performance in identifying specific conditions needs evaluation.

Purpose of the Study:

  • To quantify the accuracy of claims data in identifying DKA cases among newly diagnosed type 1 diabetes patients.
  • To estimate healthcare resource utilization in type 1 diabetes patients with and without DKA.

Main Methods:

  • Matched individuals from a diabetes registry to an all-payer claims database.
  • Evaluated DKA identification performance using type 1 diabetes and DKA codes in emergency department (ER) and inpatient (IP) settings.
  • Estimated associations between laboratory-confirmed DKA and healthcare resource utilization (ER and IP encounters).

Main Results:

  • A significant proportion (56%) of newly diagnosed type 1 diabetes patients experienced DKA.
  • Strict claims coding definitions for DKA had lower sensitivity (63%) but higher specificity (76%) compared to looser definitions (sensitivity 89%, specificity 60%).
  • Laboratory-confirmed DKA was associated with over 5 times the rate of inpatient encounters and fewer ER-only encounters.

Conclusions:

  • Claims data may not capture all DKA encounters at the time of type 1 diabetes diagnosis.
  • Further research is needed to refine coding and setting analyses for comprehensive DKA burden estimation.
Abstract

Related Concept Videos

Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...